Nantahala Capital Management, LLC
An institutional investment manager in NEW CANAAN, CT. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1472322.
- Reported value$3.00bn
- Positions307
Holdings: 307 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 152 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Ishares TR | RUSSELL 2000 ETF | 464287655 | 601 | 10.0% | 2,000,000 | Put | Reduced−50,000 |
| Ishares TR | RUSSELL 2000 ETF | 464287655 | 601 | 10.0% | 2,000,000 | Put | Reduced−50,000 |
| Peloton Interactive IncPTON | CL A COM | 70614W100 | 97.2 | 1.6% | 16,438,900 | Call | Reduced−1,500,000 |
| Peloton Interactive IncPTON | CL A COM | 70614W100 | 97.2 | 1.6% | 16,438,900 | Call | Reduced−1,500,000 |
| Herbalife Ltd | COM SHS | G4412G101 | 86.8 | 1.4% | 6,600,000 | Call | Added+1,000,000 |
| Herbalife Ltd | COM SHS | G4412G101 | 86.8 | 1.4% | 6,600,000 | Call | Added+1,000,000 |
| Viatris IncVTRS | COM | 92556V106 | 79.4 | 1.3% | 5,000,000 | Call | Unchanged |
| Viatris IncVTRS | COM | 92556V106 | 79.4 | 1.3% | 5,000,000 | Call | Unchanged |
| Bancorp Inc DelTBBK | COM | 05969A105 | 77.7 | 1.3% | 1,239,887 | Reduced−140,569 | |
| Bancorp Inc DelTBBK | COM | 05969A105 | 77.7 | 1.3% | 1,239,887 | Reduced−140,569 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 72.4 | 1.2% | 800,000 | Put | Unchanged |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 72.4 | 1.2% | 800,000 | Put | Unchanged |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 63.3 | 1.1% | 400,000 | Put | Added+100,000 |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 63.3 | 1.1% | 400,000 | Put | Added+100,000 |
| Bioventus IncBVS | COM CL A | 09075A108 | 56.6 | 0.9% | 6,000,279 | Reduced−122,124 | |
| Bioventus IncBVS | COM CL A | 09075A108 | 56.6 | 0.9% | 6,000,279 | Reduced−122,124 | |
| Hilton Grand Vacations IncHGV | COM | 43283X105 | 56.3 | 0.9% | 1,075,000 | Call | Unchanged |
| Hilton Grand Vacations IncHGV | COM | 43283X105 | 56.3 | 0.9% | 1,075,000 | Call | Unchanged |
| Hilton Grand Vacations IncHGV | COM | 43283X105 | 54.1 | 0.9% | 1,033,170 | Reduced−480,486 | |
| Hilton Grand Vacations IncHGV | COM | 43283X105 | 54.1 | 0.9% | 1,033,170 | Reduced−480,486 | |
| Savara IncSVRA | COM | 805111101 | 43.0 | 0.7% | 6,976,810 | Reduced−367,973 | |
| Savara IncSVRA | COM | 805111101 | 43.0 | 0.7% | 6,976,810 | Reduced−367,973 | |
| Eton Pharmaceuticals IncETON | COM | 29772L108 | 42.6 | 0.7% | 1,175,951 | Unchanged | |
| Eton Pharmaceuticals IncETON | COM | 29772L108 | 42.6 | 0.7% | 1,175,951 | Unchanged | |
| Amneal Pharmaceuticals IncAMRX | COM STK CL A | 03168L105 | 39.3 | 0.7% | 2,268,751 | Reduced−575,357 | |
| Amneal Pharmaceuticals IncAMRX | COM STK CL A | 03168L105 | 39.3 | 0.7% | 2,268,751 | Reduced−575,357 | |
| Evolus IncEOLS | COM | 30052C107 | 38.9 | 0.6% | 5,602,021 | Reduced−774,836 | |
| Evolus IncEOLS | COM | 30052C107 | 38.9 | 0.6% | 5,602,021 | Reduced−774,836 | |
| ETF Ser Solutions | DEFIA QUANT ETF | 26922A420 | 36.9 | 0.6% | 223,000 | Put | New+223,000 |
| ETF Ser Solutions | DEFIA QUANT ETF | 26922A420 | 36.9 | 0.6% | 223,000 | Put | New+223,000 |
| Uniqure NV | SHS | N90064101 | 36.8 | 0.6% | 800,000 | Call | Reduced−1,800,000 |
| Uniqure NV | SHS | N90064101 | 36.8 | 0.6% | 800,000 | Call | Reduced−1,800,000 |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 34.4 | 0.6% | 1,862,250 | Added+627,250 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 34.4 | 0.6% | 1,862,250 | Added+627,250 | |
| LB Pharmaceuticals IncLBRX | COM SHS | 50180M108 | 34.2 | 0.6% | 1,052,894 | Unchanged | |
| LB Pharmaceuticals IncLBRX | COM SHS | 50180M108 | 34.2 | 0.6% | 1,052,894 | Unchanged | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 33.7 | 0.6% | 200,000 | Call | New+200,000 |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 33.7 | 0.6% | 200,000 | Call | New+200,000 |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 33.5 | 0.6% | 100,000 | Put | New+100,000 |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 33.5 | 0.6% | 100,000 | Put | New+100,000 |
| Anteris Technologies GlobalAVR | COM | 03675P102 | 33.3 | 0.6% | 3,383,335 | Reduced−2,147,575 | |
| Anteris Technologies GlobalAVR | COM | 03675P102 | 33.3 | 0.6% | 3,383,335 | Reduced−2,147,575 | |
| Abeona Therapeutics IncABEO | COM NEW | 00289Y206 | 31.7 | 0.5% | 5,136,490 | Added+123,438 | |
| Abeona Therapeutics IncABEO | COM NEW | 00289Y206 | 31.7 | 0.5% | 5,136,490 | Added+123,438 | |
| Krystal Biotech IncKRYS | COM | 501147102 | 31.6 | 0.5% | 85,000 | Put | New+85,000 |
| Krystal Biotech IncKRYS | COM | 501147102 | 31.6 | 0.5% | 85,000 | Put | New+85,000 |
| Peloton Interactive IncPTON | CL A COM | 70614W100 | 30.2 | 0.5% | 5,108,995 | Reduced−6,891,005 | |
| Peloton Interactive IncPTON | CL A COM | 70614W100 | 30.2 | 0.5% | 5,108,995 | Reduced−6,891,005 | |
| Establishment Labs Holdings Inc | COM | G31249108 | 28.8 | 0.5% | 335,830 | Reduced−497,126 | |
| Establishment Labs Holdings Inc | COM | G31249108 | 28.8 | 0.5% | 335,830 | Reduced−497,126 | |
| Xtant Med Holdings IncXTNT | COM NEW | 98420P308 | 28.8 | 0.5% | 68,394,000 | Unchanged | |
| Xtant Med Holdings IncXTNT | COM NEW | 98420P308 | 28.8 | 0.5% | 68,394,000 | Unchanged | |
| Jack in the Box IncJACK | COM | 466367109 | 27.3 | 0.5% | 1,728,659 | Added+185,944 | |
| Jack in the Box IncJACK | COM | 466367109 | 27.3 | 0.5% | 1,728,659 | Added+185,944 | |
| Gogo IncGOGO | COM | 38046C109 | 27.0 | 0.4% | 8,697,731 | Reduced−184,305 | |
| Gogo IncGOGO | COM | 38046C109 | 27.0 | 0.4% | 8,697,731 | Reduced−184,305 | |
| Imax CorpIMAX | COM | 45245E109 | 26.2 | 0.4% | 658,009 | Added+142,455 | |
| Imax CorpIMAX | COM | 45245E109 | 26.2 | 0.4% | 658,009 | Added+142,455 | |
| Zevra Therapeutics IncZVRA | COM NEW | 488445206 | 25.8 | 0.4% | 1,797,476 | Reduced−724,460 | |
| Zevra Therapeutics IncZVRA | COM NEW | 488445206 | 25.8 | 0.4% | 1,797,476 | Reduced−724,460 | |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 24.9 | 0.4% | 40,000 | Call | Unchanged |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 24.9 | 0.4% | 40,000 | Call | Unchanged |
| Titan Machy IncTITN | COM | 88830R101 | 23.9 | 0.4% | 1,133,088 | Reduced−121,432 | |
| Titan Machy IncTITN | COM | 88830R101 | 23.9 | 0.4% | 1,133,088 | Reduced−121,432 | |
| RMR Group IncRMR | CL A | 74967R106 | 23.6 | 0.4% | 1,147,902 | Unchanged | |
| RMR Group IncRMR | CL A | 74967R106 | 23.6 | 0.4% | 1,147,902 | Unchanged | |
| Fossil Group IncFOSL | COM | 34988V106 | 22.8 | 0.4% | 5,505,128 | Added+101,104 | |
| Fossil Group IncFOSL | COM | 34988V106 | 22.8 | 0.4% | 5,505,128 | Added+101,104 | |
| Fox Factory HLDG CorpFOXF | COM | 35138V102 | 22.2 | 0.4% | 1,310,695 | Reduced−177,605 | |
| Fox Factory HLDG CorpFOXF | COM | 35138V102 | 22.2 | 0.4% | 1,310,695 | Reduced−177,605 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 22.1 | 0.4% | 820,481 | Reduced−75,000 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 22.1 | 0.4% | 820,481 | Reduced−75,000 | |
| Ridenow Group IncRDNW | COM CL B | 781386305 | 21.8 | 0.4% | 3,272,845 | Unchanged | |
| Ridenow Group IncRDNW | COM CL B | 781386305 | 21.8 | 0.4% | 3,272,845 | Unchanged | |
| Snap IncSNAP | CL A | 83304A106 | 21.3 | 0.4% | 4,800,000 | Call | New+4,800,000 |
| Snap IncSNAP | CL A | 83304A106 | 21.3 | 0.4% | 4,800,000 | Call | New+4,800,000 |
| Uniqure NV | SHS | N90064101 | 21.0 | 0.3% | 455,660 | Added+218,582 | |
| Uniqure NV | SHS | N90064101 | 21.0 | 0.3% | 455,660 | Added+218,582 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 21.0 | 0.3% | 2,951,030 | Added+833,333 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 21.0 | 0.3% | 2,951,030 | Added+833,333 | |
| Agomab Therapeutics NVAGMB | SPONSORED ADS | 00860C102 | 20.4 | 0.3% | 1,568,188 | Added+368,188 | |
| Agomab Therapeutics NVAGMB | SPONSORED ADS | 00860C102 | 20.4 | 0.3% | 1,568,188 | Added+368,188 | |
| Fulcrum Therapeutics IncFULC | COM | 359616109 | 20.0 | 0.3% | 5,475,040 | Added+2,425,000 | |
| Fulcrum Therapeutics IncFULC | COM | 359616109 | 20.0 | 0.3% | 5,475,040 | Added+2,425,000 | |
| Benitec Biopharma IncBNTC | COM NEW | 08205P209 | 19.9 | 0.3% | 1,488,371 | Added+50,000 | |
| Benitec Biopharma IncBNTC | COM NEW | 08205P209 | 19.9 | 0.3% | 1,488,371 | Added+50,000 | |
| Adma Biologics IncADMA | COM | 000899104 | 19.8 | 0.3% | 2,359,993 | New+2,359,993 | |
| Adma Biologics IncADMA | COM | 000899104 | 19.8 | 0.3% | 2,359,993 | New+2,359,993 | |
| Camping World Holdings IncCWH | CL A | 13462K109 | 19.5 | 0.3% | 2,551,055 | Reduced−708,219 | |
| Camping World Holdings IncCWH | CL A | 13462K109 | 19.5 | 0.3% | 2,551,055 | Reduced−708,219 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 19.0 | 0.3% | 1,901,160 | Reduced−86,237 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 19.0 | 0.3% | 1,901,160 | Reduced−86,237 | |
| Mimedx Group IncMDXG | COM | 602496101 | 18.4 | 0.3% | 4,767,552 | Added+1,370,253 | |
| Mimedx Group IncMDXG | COM | 602496101 | 18.4 | 0.3% | 4,767,552 | Added+1,370,253 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 17.8 | 0.3% | 133,759 | Reduced−3,478 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 17.8 | 0.3% | 133,759 | Reduced−3,478 | |
| Usana Health Sciences IncUSNA | COM | 90328M107 | 17.3 | 0.3% | 810,074 | Unchanged | |
| Usana Health Sciences IncUSNA | COM | 90328M107 | 17.3 | 0.3% | 810,074 | Unchanged | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 15.8 | 0.3% | 651,993 | Unchanged | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 15.8 | 0.3% | 651,993 | Unchanged | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 15.7 | 0.3% | 500,659 | Reduced−749,793 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 15.7 | 0.3% | 500,659 | Reduced−749,793 | |
| Geron CorpGERN | COM | 374163103 | 15.6 | 0.3% | 12,225,000 | Added+1,000,000 | |
| Geron CorpGERN | COM | 374163103 | 15.6 | 0.3% | 12,225,000 | Added+1,000,000 | |
| VOR Biopharma IncVOR | COM NEW | 929033207 | 15.6 | 0.3% | 845,000 | New+845,000 | |
| VOR Biopharma IncVOR | COM NEW | 929033207 | 15.6 | 0.3% | 845,000 | New+845,000 | |
| Camping World Holdings IncCWH | CL A | 13462K109 | 15.3 | 0.3% | 2,000,000 | Call | Unchanged |
| Camping World Holdings IncCWH | CL A | 13462K109 | 15.3 | 0.3% | 2,000,000 | Call | Unchanged |
| Keros Therapeutics IncKROS | COM | 492327101 | 15.1 | 0.3% | 1,410,419 | Added+50,000 | |
| Keros Therapeutics IncKROS | COM | 492327101 | 15.1 | 0.3% | 1,410,419 | Added+50,000 | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 14.8 | 0.2% | 1,346,731 | Reduced−800,000 | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 14.8 | 0.2% | 1,346,731 | Reduced−800,000 | |
| Apyx Medical CorporationAPYX | COM | 03837C106 | 14.7 | 0.2% | 3,270,248 | Reduced−170,056 | |
| Apyx Medical CorporationAPYX | COM | 03837C106 | 14.7 | 0.2% | 3,270,248 | Reduced−170,056 | |
| Jefferson Capital IncJCAP | COM | 47248R103 | 14.6 | 0.2% | 750,000 | Unchanged | |
| Jefferson Capital IncJCAP | COM | 47248R103 | 14.6 | 0.2% | 750,000 | Unchanged | |
| Herbalife Ltd | COM SHS | G4412G101 | 14.6 | 0.2% | 1,109,154 | Reduced−244,499 | |
| Herbalife Ltd | COM SHS | G4412G101 | 14.6 | 0.2% | 1,109,154 | Reduced−244,499 | |
| Planet Fitness Master IssuerPLNT | CL A | 72703H101 | 14.6 | 0.2% | 279,000 | New+279,000 | |
| Planet Fitness Master IssuerPLNT | CL A | 72703H101 | 14.6 | 0.2% | 279,000 | New+279,000 | |
| Verastem IncVSTM | COM NEW | 92337C203 | 13.7 | 0.2% | 3,584,820 | Unchanged | |
| Verastem IncVSTM | COM NEW | 92337C203 | 13.7 | 0.2% | 3,584,820 | Unchanged | |
| Fox Factory HLDG CorpFOXF | COM | 35138V102 | 13.6 | 0.2% | 800,000 | Call | Unchanged |
| Fox Factory HLDG CorpFOXF | COM | 35138V102 | 13.6 | 0.2% | 800,000 | Call | Unchanged |
| Distribution Solutions GRP IDSGR | COM | 520776105 | 13.5 | 0.2% | 494,581 | Unchanged | |
| Distribution Solutions GRP IDSGR | COM | 520776105 | 13.5 | 0.2% | 494,581 | Unchanged | |
| Rayonier Advanced Matls IncRYAM | COM | 75508B104 | 13.3 | 0.2% | 1,697,726 | Added+97,726 | |
| Rayonier Advanced Matls IncRYAM | COM | 75508B104 | 13.3 | 0.2% | 1,697,726 | Added+97,726 | |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | 13.3 | 0.2% | 1,250,000 | Unchanged | |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | 13.3 | 0.2% | 1,250,000 | Unchanged | |
| ADC Therapeutics SA | SHS | H0036K147 | 13.2 | 0.2% | 12,326,184 | Added+6,728,751 | |
| ADC Therapeutics SA | SHS | H0036K147 | 13.2 | 0.2% | 12,326,184 | Added+6,728,751 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 12.9 | 0.2% | 222,146 | Reduced−16,600 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 12.9 | 0.2% | 222,146 | Reduced−16,600 | |
| Opus Genetics IncIRD | COM | 67577R102 | 12.6 | 0.2% | 3,061,359 | Added+1,380,029 | |
| Opus Genetics IncIRD | COM | 67577R102 | 12.6 | 0.2% | 3,061,359 | Added+1,380,029 | |
| Janux Therapeutics IncJANX | COM | 47103J105 | 12.4 | 0.2% | 809,914 | Unchanged | |
| Janux Therapeutics IncJANX | COM | 47103J105 | 12.4 | 0.2% | 809,914 | Unchanged | |
| Chime Finl IncCHYM | COM SHS CL A | 16935C109 | 12.3 | 0.2% | 600,000 | Call | Unchanged |
| Chime Finl IncCHYM | COM SHS CL A | 16935C109 | 12.3 | 0.2% | 600,000 | Call | Unchanged |
| Amanat Acquisition Corp | CL A ORD | G0375M101 | 12.2 | 0.2% | 1,200,000 | New+1,200,000 | |
| Amanat Acquisition Corp | CL A ORD | G0375M101 | 12.2 | 0.2% | 1,200,000 | New+1,200,000 | |
| Inspire Med Sys IncINSP | COM | 457730109 | 12.0 | 0.2% | 269,474 | New+269,474 | |
| Inspire Med Sys IncINSP | COM | 457730109 | 12.0 | 0.2% | 269,474 | New+269,474 | |
| 1 800 Flowers Com IncFLWS | CL A | 68243Q106 | 11.7 | 0.2% | 3,375,065 | Unchanged | |
| 1 800 Flowers Com IncFLWS | CL A | 68243Q106 | 11.7 | 0.2% | 3,375,065 | Unchanged | |
| X4 Pharmaceuticals IncXFOR | COM NEW | 98420X202 | 11.4 | 0.2% | 2,449,468 | Unchanged | |
| X4 Pharmaceuticals IncXFOR | COM NEW | 98420X202 | 11.4 | 0.2% | 2,449,468 | Unchanged | |
| Ridenow Group IncRDNW | COM CL B | 781386305 | 11.3 | 0.2% | 1,700,000 | Call | Unchanged |
| Ridenow Group IncRDNW | COM CL B | 781386305 | 11.3 | 0.2% | 1,700,000 | Call | Unchanged |
| Integer Holdings CorpITGR | COM | 45826H109 | 10.4 | 0.2% | 111,302 | Reduced−60,698 | |
| Integer Holdings CorpITGR | COM | 45826H109 | 10.4 | 0.2% | 111,302 | Reduced−60,698 | |
| Inventiva SAIVA | ADS | 46124U107 | 10.2 | 0.2% | 2,686,393 | New+2,686,393 | |
| Inventiva SAIVA | ADS | 46124U107 | 10.2 | 0.2% | 2,686,393 | New+2,686,393 | |
| Industrial Logistics Pptys TILPT | COM SHS BEN INT | 456237106 | 9.9 | 0.2% | 1,111,153 | Reduced−567,820 | |
| Industrial Logistics Pptys TILPT | COM SHS BEN INT | 456237106 | 9.9 | 0.2% | 1,111,153 | Reduced−567,820 | |
| Duolingo IncDUOL | CL A COM | 26603R106 | 9.6 | 0.2% | 83,877 | Reduced−16,123 | |
| Duolingo IncDUOL | CL A COM | 26603R106 | 9.6 | 0.2% | 83,877 | Reduced−16,123 | |
| Reservoir Media IncRSVR | COM | 76119X105 | 9.3 | 0.2% | 940,960 | Unchanged | |
| Reservoir Media IncRSVR | COM | 76119X105 | 9.3 | 0.2% | 940,960 | Unchanged | |
| Service Properties Trust | SERVICE PPTYS TR | 81761L102 | 9.0 | 0.1% | 5,322,641 | Reduced−1,735,246 | |
| Fractyl Health Inc | COM | 35168W103 | 9.0 | 0.1% | 11,289,096 | Reduced−2,075,423 | |
| Fractyl Health Inc | COM | 35168W103 | 9.0 | 0.1% | 11,289,096 | Reduced−2,075,423 | |
| DHI Group IncDHX | COM | 23331S100 | 8.8 | 0.1% | 2,374,027 | Unchanged | |
| DHI Group IncDHX | COM | 23331S100 | 8.8 | 0.1% | 2,374,027 | Unchanged | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 8.7 | 0.1% | 486,684 | Reduced−49,000 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 8.7 | 0.1% | 486,684 | Reduced−49,000 | |
| Korro Bio IncKRRO | COM | 500946108 | 8.7 | 0.1% | 660,036 | Unchanged | |
| Korro Bio IncKRRO | COM | 500946108 | 8.7 | 0.1% | 660,036 | Unchanged | |
| Alector IncALEC | COM | 014442107 | 8.7 | 0.1% | 4,318,109 | Added+1,502,126 | |
| Alector IncALEC | COM | 014442107 | 8.7 | 0.1% | 4,318,109 | Added+1,502,126 | |
| Noodles & CoNDLS | CL A NEW | 65540B303 | 8.3 | 0.1% | 553,746 | Unchanged | |
| Noodles & CoNDLS | CL A NEW | 65540B303 | 8.3 | 0.1% | 553,746 | Unchanged | |
| RHRH | COM | 74967X103 | 8.2 | 0.1% | 50,000 | Call | Unchanged |
| RHRH | COM | 74967X103 | 8.2 | 0.1% | 50,000 | Call | Unchanged |
| Codexis IncCDXS | COM | 192005106 | 8.2 | 0.1% | 3,623,613 | Reduced−500,000 | |
| Codexis IncCDXS | COM | 192005106 | 8.2 | 0.1% | 3,623,613 | Reduced−500,000 | |
| Perspective Therapeutics IncCATX | COM NEW | 46489V302 | 7.9 | 0.1% | 2,325,450 | New+2,325,450 | |
| Perspective Therapeutics IncCATX | COM NEW | 46489V302 | 7.9 | 0.1% | 2,325,450 | New+2,325,450 | |
| Bancorp Inc DelTBBK | COM | 05969A105 | 7.9 | 0.1% | 125,800 | Call | Unchanged |
| Bancorp Inc DelTBBK | COM | 05969A105 | 7.9 | 0.1% | 125,800 | Call | Unchanged |
| Irenic Acquisition Corp | UNIT 04/10/2031 | G4939F115 | 7.6 | 0.1% | 750,000 | New+750,000 | |
| Irenic Acquisition Corp | UNIT 04/10/2031 | G4939F115 | 7.6 | 0.1% | 750,000 | New+750,000 | |
| Uniqure NV | SHS | N90064101 | 7.4 | 0.1% | 161,500 | Put | New+161,500 |
| Uniqure NV | SHS | N90064101 | 7.4 | 0.1% | 161,500 | Put | New+161,500 |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 7.2 | 0.1% | 278,000 | Unchanged | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 7.2 | 0.1% | 278,000 | Unchanged | |
| Viemed Healthcare IncVMD | COM | 92663R105 | 7.2 | 0.1% | 632,445 | Reduced−251,338 | |
| Viemed Healthcare IncVMD | COM | 92663R105 | 7.2 | 0.1% | 632,445 | Reduced−251,338 | |
| Unicycive Therapeutics IncUNCY | COM NEW | 90466Y202 | 6.6 | 0.1% | 1,401,447 | Added+462,245 | |
| Unicycive Therapeutics IncUNCY | COM NEW | 90466Y202 | 6.6 | 0.1% | 1,401,447 | Added+462,245 | |
| Traeger IncCOOK | COM NEW | 89269P202 | 6.5 | 0.1% | 82,831 | Reduced−19,577 | |
| Traeger IncCOOK | COM NEW | 89269P202 | 6.5 | 0.1% | 82,831 | Reduced−19,577 | |
| Forrester Resh IncFORR | COM | 346563109 | 6.4 | 0.1% | 763,446 | Added+69,024 | |
| Forrester Resh IncFORR | COM | 346563109 | 6.4 | 0.1% | 763,446 | Added+69,024 | |
| Abeona Therapeutics IncABEO | COM NEW | 00289Y206 | 6.3 | 0.1% | 1,020,000 | Call | Unchanged |
| Abeona Therapeutics IncABEO | COM NEW | 00289Y206 | 6.3 | 0.1% | 1,020,000 | Call | Unchanged |
| Lexeo Therapeutics IncLXEO | COM | 52886X107 | 6.1 | 0.1% | 1,300,000 | Added+100,000 | |
| Lexeo Therapeutics IncLXEO | COM | 52886X107 | 6.1 | 0.1% | 1,300,000 | Added+100,000 | |
| RHRH | COM | 74967X103 | 6.0 | 0.1% | 36,686 | Reduced−21,105 | |
| RHRH | COM | 74967X103 | 6.0 | 0.1% | 36,686 | Reduced−21,105 | |
| Envoy Medical IncCOCH | CL A | 29415V109 | 6.0 | <0.1% | 7,650,000 | Unchanged | |
| Envoy Medical IncCOCH | CL A | 29415V109 | 6.0 | <0.1% | 7,650,000 | Unchanged | |
| Eloxx Pharmaceuticals IncELOX | COM NEW | 29014R301 | 5.6 | <0.1% | 400,000 | New+400,000 | |
| Eloxx Pharmaceuticals IncELOX | COM NEW | 29014R301 | 5.6 | <0.1% | 400,000 | New+400,000 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 5.5 | <0.1% | 2,701,863 | Unchanged | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 5.5 | <0.1% | 2,701,863 | Unchanged | |
| First Tracks BiotherapeuticsTRAX | ORD SHS | 337185102 | 5.0 | <0.1% | 250,000 | New+250,000 | |
| First Tracks BiotherapeuticsTRAX | ORD SHS | 337185102 | 5.0 | <0.1% | 250,000 | New+250,000 | |
| Mara Holdings Inc | NOTE3/0 | 565788AF3 | 5.0 | <0.1% | $5,000,000 principal | Unchanged | |
| Mara Holdings Inc | NOTE3/0 | 565788AF3 | 5.0 | <0.1% | $5,000,000 principal | Unchanged | |
| Hain Celestial Group IncHAIN | COM | 405217100 | 4.8 | <0.1% | 8,528,789 | Unchanged | |
| Hain Celestial Group IncHAIN | COM | 405217100 | 4.8 | <0.1% | 8,528,789 | Unchanged | |
| Alta Equipment Group IncALTG | COMMON STOCK | 02128L106 | 4.7 | <0.1% | 724,774 | Reduced−210,000 | |
| Alta Equipment Group IncALTG | COMMON STOCK | 02128L106 | 4.7 | <0.1% | 724,774 | Reduced−210,000 | |
| Orthopediatrics CorpKIDS | COM | 68752L100 | 4.6 | <0.1% | 242,342 | Added+42,893 | |
| Orthopediatrics CorpKIDS | COM | 68752L100 | 4.6 | <0.1% | 242,342 | Added+42,893 | |
| Altimmune IncALT | COM NEW | 02155H200 | 4.6 | <0.1% | 1,500,000 | New+1,500,000 | |
| Altimmune IncALT | COM NEW | 02155H200 | 4.6 | <0.1% | 1,500,000 | New+1,500,000 | |
| Trisalus Life Sciences IncTLSI | COM | 89680M101 | 4.6 | <0.1% | 1,000,000 | Reduced−1,070,827 | |
| Trisalus Life Sciences IncTLSI | COM | 89680M101 | 4.6 | <0.1% | 1,000,000 | Reduced−1,070,827 | |
| Tela Bio IncTELA | COM | 872381108 | 4.4 | <0.1% | 5,894,114 | Added+750,000 | |
| Tela Bio IncTELA | COM | 872381108 | 4.4 | <0.1% | 5,894,114 | Added+750,000 | |
| The One Group Hospitality inSTKS | COM | 88338K103 | 4.3 | <0.1% | 2,121,084 | Unchanged | |
| The One Group Hospitality inSTKS | COM | 88338K103 | 4.3 | <0.1% | 2,121,084 | Unchanged | |
| Dariohealth CorpDRIO | COM | 23725P308 | 4.0 | <0.1% | 610,691 | Added+1 | |
| Dariohealth CorpDRIO | COM | 23725P308 | 4.0 | <0.1% | 610,691 | Added+1 | |
| Immunic IncIMUX | COM NEW | 4525EP200 | 3.9 | <0.1% | 250,646 | New+250,646 | |
| Immunic IncIMUX | COM NEW | 4525EP200 | 3.9 | <0.1% | 250,646 | New+250,646 | |
| ZAI Lab LtdZLAB | ADR | 98887Q104 | 3.8 | <0.1% | 200,000 | New+200,000 | |
| ZAI Lab LtdZLAB | ADR | 98887Q104 | 3.8 | <0.1% | 200,000 | New+200,000 | |
| Talphera IncTLPH | COM NEW | 00444T209 | 3.6 | <0.1% | 3,492,519 | Unchanged | |
| Talphera IncTLPH | COM NEW | 00444T209 | 3.6 | <0.1% | 3,492,519 | Unchanged | |
| Chime Finl IncCHYM | COM SHS CL A | 16935C109 | 3.5 | <0.1% | 172,119 | Reduced−27,881 | |
| Chime Finl IncCHYM | COM SHS CL A | 16935C109 | 3.5 | <0.1% | 172,119 | Reduced−27,881 | |
| Venu HLDG CorpVENU | COM | 92333E104 | 3.5 | <0.1% | 1,546,705 | Reduced−500,000 | |
| Venu HLDG CorpVENU | COM | 92333E104 | 3.5 | <0.1% | 1,546,705 | Reduced−500,000 | |
| Payoneer Global IncPAYO | COM | 70451X104 | 3.4 | <0.1% | 483,836 | Unchanged | |
| Payoneer Global IncPAYO | COM | 70451X104 | 3.4 | <0.1% | 483,836 | Unchanged | |
| Elutia IncELUT | CL A COM | 05479K106 | 3.1 | <0.1% | 3,184,947 | Unchanged | |
| Elutia IncELUT | CL A COM | 05479K106 | 3.1 | <0.1% | 3,184,947 | Unchanged | |
| Kailera Therapeutics IncKLRA | COMMON STOCK | 482931102 | 3.1 | <0.1% | 140,000 | New+140,000 | |
| Kailera Therapeutics IncKLRA | COMMON STOCK | 482931102 | 3.1 | <0.1% | 140,000 | New+140,000 | |
| Rallybio CorpRLYB | COM | 75120L209 | 3.0 | <0.1% | 188,422 | Reduced−112,213 | |
| Rallybio CorpRLYB | COM | 75120L209 | 3.0 | <0.1% | 188,422 | Reduced−112,213 | |
| Artiva Biotherapeutics IncARTV | COM | 04317A107 | 2.9 | <0.1% | 300,000 | New+300,000 | |
| Artiva Biotherapeutics IncARTV | COM | 04317A107 | 2.9 | <0.1% | 300,000 | New+300,000 | |
| Destination XL Group IncDXLG | COM | 25065K104 | 2.8 | <0.1% | 4,141,740 | Unchanged | |
| Destination XL Group IncDXLG | COM | 25065K104 | 2.8 | <0.1% | 4,141,740 | Unchanged | |
| Editas Medicine IncEDIT | COM | 28106W103 | 2.8 | <0.1% | 852,700 | New+852,700 | |
| Editas Medicine IncEDIT | COM | 28106W103 | 2.8 | <0.1% | 852,700 | New+852,700 | |
| Ehealth IncEHTH | COM | 28238P109 | 2.6 | <0.1% | 1,761,441 | Unchanged | |
| Ehealth IncEHTH | COM | 28238P109 | 2.6 | <0.1% | 1,761,441 | Unchanged | |
| Jatt II Acquisition Corp | ORD SHS | G50765109 | 2.6 | <0.1% | 225,000 | New+225,000 | |
| Jatt II Acquisition Corp | ORD SHS | G50765109 | 2.6 | <0.1% | 225,000 | New+225,000 | |
| Arvinas IncARVN | COM | 04335A105 | 2.5 | <0.1% | 300,000 | Unchanged | |
| Arvinas IncARVN | COM | 04335A105 | 2.5 | <0.1% | 300,000 | Unchanged | |
| Reading International IncRDI | CL A | 755408101 | 2.5 | <0.1% | 1,921,088 | Unchanged | |
| Reading International IncRDI | CL A | 755408101 | 2.5 | <0.1% | 1,921,088 | Unchanged | |
| Inspiremd IncNSPR | COM | 45779A846 | 2.4 | <0.1% | 3,376,484 | Unchanged | |
| Inspiremd IncNSPR | COM | 45779A846 | 2.4 | <0.1% | 3,376,484 | Unchanged | |
| Aytu Biopharma IncAYTU | COM | 054754858 | 2.3 | <0.1% | 1,086,812 | Unchanged | |
| Aytu Biopharma IncAYTU | COM | 054754858 | 2.3 | <0.1% | 1,086,812 | Unchanged | |
| Akebia Threapeutics IncAKBA | COM | 00972D105 | 2.3 | <0.1% | 2,000,000 | Unchanged | |
| Akebia Threapeutics IncAKBA | COM | 00972D105 | 2.3 | <0.1% | 2,000,000 | Unchanged | |
| Scully Royalty Ltd | COM SHS | G7T96K107 | 2.3 | <0.1% | 368,182 | Unchanged | |
| Scully Royalty Ltd | COM SHS | G7T96K107 | 2.3 | <0.1% | 368,182 | Unchanged | |
| Entrada Therapeutics IncTRDA | COM | 29384C108 | 2.2 | <0.1% | 300,575 | Added+141,243 | |
| Entrada Therapeutics IncTRDA | COM | 29384C108 | 2.2 | <0.1% | 300,575 | Added+141,243 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 2.0 | <0.1% | 35,200 | Call | Unchanged |
| Vaxcyte IncPCVX | COM | 92243G108 | 2.0 | <0.1% | 35,200 | Call | Unchanged |
| Gaia Inc NewGAIA | CL A | 36269P104 | 1.9 | <0.1% | 914,618 | Unchanged | |
| Gaia Inc NewGAIA | CL A | 36269P104 | 1.9 | <0.1% | 914,618 | Unchanged | |
| Americas Car-Mart IncCRMT | COM | 03062T105 | 1.8 | <0.1% | 644,686 | Unchanged | |
| Americas Car-Mart IncCRMT | COM | 03062T105 | 1.8 | <0.1% | 644,686 | Unchanged | |
| ALX Oncology Holdings IncALXO | COM | 00166B105 | 1.6 | <0.1% | 750,000 | New+750,000 | |
| ALX Oncology Holdings IncALXO | COM | 00166B105 | 1.6 | <0.1% | 750,000 | New+750,000 | |
| Precision Optics Corp Inc MaPOCI | COM NEW | 740294400 | 1.4 | <0.1% | 280,000 | Unchanged | |
| Precision Optics Corp Inc MaPOCI | COM NEW | 740294400 | 1.4 | <0.1% | 280,000 | Unchanged | |
| BRC Inc | COM CL A | 05601U105 | 1.4 | <0.1% | 1,257,171 | Reduced−1,373,346 | |
| BRC Inc | COM CL A | 05601U105 | 1.4 | <0.1% | 1,257,171 | Reduced−1,373,346 | |
| Vyne Therapeutics Inc | COM | 92941V308 | 1.3 | <0.1% | 2,000,000 | Unchanged | |
| Vyne Therapeutics Inc | COM | 92941V308 | 1.3 | <0.1% | 2,000,000 | Unchanged | |
| Curis Inc | COM | 231269309 | 1.0 | <0.1% | 1,978,876 | Reduced−21,124 | |
| Altisource Portfolio Solutio | *W EXP 04/30/203 | L0175J112 | 1.0 | <0.1% | 2,477,312 | Unchanged | |
| Altisource Portfolio Solutio | *W EXP 04/30/203 | L0175J112 | 1.0 | <0.1% | 2,477,312 | Unchanged | |
| Senti Biosciences HoldingsSNTI | COM NEW | 816944102 | 1.0 | <0.1% | 888,000 | New+888,000 | |
| Acme Utd CorpACU | COM | 004816104 | 1.0 | <0.1% | 20,427 | Unchanged | |
| Acme Utd CorpACU | COM | 004816104 | 1.0 | <0.1% | 20,427 | Unchanged | |
| Perfect Corp | CL A ORD SHS | G7006A109 | 1.0 | <0.1% | 583,925 | Unchanged | |
| Perfect Corp | CL A ORD SHS | G7006A109 | 1.0 | <0.1% | 583,925 | Unchanged | |
| Snap IncSNAP | CL A | 83304A106 | 0.9 | <0.1% | 200,000 | New+200,000 | |
| Snap IncSNAP | CL A | 83304A106 | 0.9 | <0.1% | 200,000 | New+200,000 | |
| Altisource Portfolio Solutio | *W EXP 04/02/202 | L0175J120 | 0.7 | <0.1% | 2,477,312 | Unchanged | |
| Altisource Portfolio Solutio | *W EXP 04/02/202 | L0175J120 | 0.7 | <0.1% | 2,477,312 | Unchanged | |
| Cellectar Biosciences IncCLRB | COM NEW | 15117F880 | 0.6 | <0.1% | 219,998 | New+219,998 | |
| Cellectar Biosciences IncCLRB | COM NEW | 15117F880 | 0.6 | <0.1% | 219,998 | New+219,998 | |
| Spar Group IncSGRP | COM | 784933103 | 0.5 | <0.1% | 660,688 | Unchanged | |
| Spar Group IncSGRP | COM | 784933103 | 0.5 | <0.1% | 660,688 | Unchanged | |
| Azitra IncAZTR | COM NEW | 05479L302 | 0.4 | <0.1% | 2,213,613 | New+2,213,613 | |
| Azitra IncAZTR | COM NEW | 05479L302 | 0.4 | <0.1% | 2,213,613 | New+2,213,613 | |
| Biomx Inc | COM NEW | 09090D509 | 0.2 | <0.1% | 634,995 | Added+520,200 | |
| Biomx Inc | COM NEW | 09090D509 | 0.2 | <0.1% | 634,995 | Added+520,200 | |
| Aprea Therapeutics IncAPRE | COM NEW | 03836J201 | 0.2 | <0.1% | 205,760 | Unchanged | |
| Aprea Therapeutics IncAPRE | COM NEW | 03836J201 | 0.2 | <0.1% | 205,760 | Unchanged | |
| Guardforce Ai Co Ltd | *W EXP 10/01/202 | G4236L120 | 0.0 | <0.1% | 154,205 | Unchanged | |
| Guardforce Ai Co Ltd | *W EXP 10/01/202 | G4236L120 | 0.0 | <0.1% | 154,205 | Unchanged |
Sold out: 25 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Achieve Life Science IncACHV | COM | 004468500 | 0.0 | 0.0% | 0 | Sold out−648,885 | |
| Align Technology IncALGN | COM | 016255101 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Assertio Holdings Inc | COM NEW | 04546C304 | 0.0 | 0.0% | 0 | Sold out−692,335 | |
| Caesars Entertainment Inc NeCZR | COM | 12769G100 | 0.0 | 0.0% | 0 | Sold out−150,000 | |
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−254,803 | |
| CG Oncology IncCGON | COM | 156944100 | 0.0 | 0.0% | 0 | Sold out−49,449 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 0.0 | 0.0% | 0 | Sold out−250,000 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 0.0 | 0.0% | 0 | Sold out−67,282 | |
| Disc Medicine IncIRON | COM | 254604101 | 0.0 | 0.0% | 0 | Sold out−25,653 | |
| Disc Medicine IncIRON | COM | 254604101 | 0.0 | 0.0% | 0 | Put | Sold out−41,000 |
| Grace Therapeutics IncGRCE | COM | 00439U104 | 0.0 | 0.0% | 0 | Sold out−728,203 | |
| Immunic Inc | COM | 4525EP101 | 0.0 | 0.0% | 0 | Sold out−2,506,491 | |
| Kosmos Energy LtdKOS | COM | 500688106 | 0.0 | 0.0% | 0 | Sold out−1,844,194 | |
| NN IncNNBR | COM | 629337106 | 0.0 | 0.0% | 0 | Sold out−2,441,416 | |
| Pepgen IncPEPG | COM | 713317105 | 0.0 | 0.0% | 0 | Sold out−681,158 | |
| Perfect Corp | *W EXP 10/28/202 | G7006A117 | 0.0 | 0.0% | 0 | Sold out−16,075 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Senti Biosciences Inc | COM NEW | 81726A209 | 0.0 | 0.0% | 0 | Sold out−888,000 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−1,744,124 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Call | Sold out−750,000 |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 0.0 | 0.0% | 0 | Sold out−1,165,078 | |
| Tela Bio IncTELA | COM | 872381108 | 0.0 | 0.0% | 0 | Call | Sold out−750,000 |
| Teva Pharmaceutical Inds Ltd | SPONSORED ADS | 881624209 | 0.0 | 0.0% | 0 | Call | Sold out−1,500,000 |
| Upstream Bio IncUPB | COM | 91678A107 | 0.0 | 0.0% | 0 | Sold out−400,000 | |
| Xencor IncXNCR | COM | 98401F105 | 0.0 | 0.0% | 0 | Sold out−264,639 |
Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-097253 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.